This similar mechanism has also been observed in glioma, where FGL2 interacts with thrombin and tissue factors to induce a hypercoagulable state within the tumor, ultimately promoting tumor angiogenesis and metastasis [166]. This evidence concerns the gene FGL2 and central nervous system cancer.